BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20337601)

  • 1. Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes.
    Okubo A; Arimura N; Abematsu N; Sakamoto T
    Acta Ophthalmol; 2010 Jun; 88(4):e107-14. PubMed ID: 20337601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy.
    Musashi K; Tsujikawa A; Hirami Y; Otani A; Yodoi Y; Tamura H; Yoshimura N
    Am J Ophthalmol; 2007 May; 143(5):883-885. PubMed ID: 17452180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of polypoidal choroidal vasculopathy and visual outcomes in the absence of classic choroidal neovascularization.
    Yamaoka S; Okada AA; Sugahara M; Hida T
    Ophthalmologica; 2010; 224(3):147-52. PubMed ID: 19738395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: a report of 10 eyes.
    Goldman DR; Freund KB; McCannel CA; Sarraf D
    Retina; 2013 Jan; 33(1):48-55. PubMed ID: 22836900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observation of polypoidal choroidal vasculopathy].
    Zou WJ; Wen F; Wu ZF; Huang SZ; Zhang J; Luo GW
    Zhonghua Yan Ke Za Zhi; 2011 Jan; 47(1):39-44. PubMed ID: 21418926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal pigment epithelial tear in polypoidal choroidal vasculopathy.
    Tsujikawa A; Hirami Y; Nakanishi H; Ojima Y; Aikawa H; Tamura H; Otani A; Yoshimura N
    Retina; 2007 Sep; 27(7):832-8. PubMed ID: 17891005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
    Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H
    Retina; 2009; 29(7):960-5. PubMed ID: 19491727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy.
    Byeon SH; Lew YJ; Lee SC; Kwon OW
    Acta Ophthalmol; 2010 Sep; 88(6):660-8. PubMed ID: 19563374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.
    Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R; Takami K
    Am J Ophthalmol; 2010 Nov; 150(5):674-682.e1. PubMed ID: 20691424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.
    Nishijima K; Takahashi M; Akita J; Katsuta H; Tanemura M; Aikawa H; Mandai M; Takagi H; Kiryu J; Honda Y
    Am J Ophthalmol; 2004 Apr; 137(4):770-3. PubMed ID: 15059729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
    Lai TY; Lee GK; Luk FO; Lam DS
    Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability.
    Sasahara M; Tsujikawa A; Musashi K; Gotoh N; Otani A; Mandai M; Yoshimura N
    Am J Ophthalmol; 2006 Oct; 142(4):601-7. PubMed ID: 17011852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic polypoidal choroidal vasculopathy of the macula.
    Moorthy RS; Lyon AT; Rabb MF; Spaide RF; Yannuzzi LA; Jampol LM
    Ophthalmology; 1998 Aug; 105(8):1380-5. PubMed ID: 9709746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications.
    Mantel I; Schalenbourg A; Zografos L
    Am J Ophthalmol; 2012 May; 153(5):910-922.e2. PubMed ID: 22310077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.
    Song MH; Ryu HW; Roh YJ
    Ophthalmologica; 2011; 226(3):119-26. PubMed ID: 21757883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
    Saito M; Iida T; Kano M
    Retina; 2011 Sep; 31(8):1589-97. PubMed ID: 21654347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years.
    van Zeeburg EJ; Maaijwee KJ; Missotten TO; Heimann H; van Meurs JC
    Am J Ophthalmol; 2012 Jan; 153(1):120-7.e2. PubMed ID: 21907969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy.
    Saito M; Iida T; Nagayama D
    Retina; 2008 Mar; 28(3):459-64. PubMed ID: 18327139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma.
    Mauget-Faÿsse M; Cornut PL; Quaranta El-Maftouhi M; Leys A
    Am J Ophthalmol; 2006 Dec; 142(6):970-5. PubMed ID: 17046703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular complications on the border of an inferior staphyloma associated with tilted disc syndrome.
    Nakanishi H; Tsujikawa A; Gotoh N; Hayashi H; Iwama D; Tamura H; Otani A; Yoshimura N
    Retina; 2008; 28(10):1493-501. PubMed ID: 18667957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.